Skip to content
Politically.com Search all
Menu

2025 · 2nd Quarter (Apr 1 - June 30)

ASTELLAS PHARMA US, INC

Filed by THEGROUP DC, LLC.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
2nd Quarter - Report
Posted
Jul 21, 2025
Income
$70,000.00
Expenses
Not reported
Filing UUID
50934d0c-aae3-479c-8dd3-6cfb801f3a79
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

H.R. 1300, PSA Screening for HIM Act Prostate-Specific Antigen Screening for High-risk Insured Men Act Issues related to the treatment of menopause and womens health at mid-life Issues related to the Congressional Vision CARE Caucus

Literal federal measure citations: H.R. 1300

PHA · Pharmacy

H.R. 1300, PSA Screening for HIM Act Prostate-Specific Antigen Screening for High-risk Insured Men Act Issues related to the treatment of menopause and womens health at mid-life Issues related to the Congressional Vision CARE Caucus

Literal federal measure citations: H.R. 1300

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.